• Differentiate the clinical, radiologic, and immunopathologic features of MOGAD and NMOSD.​

  • Interpret antibody testing results and understand their diagnostic implications.​

  • Recognize imaging patterns that distinguish MOGAD from NMOSD on MRI.​

  • Apply evidence-based strategies for acute and chronic treatment of both conditions.​

  • Discuss emerging controversies and evolving insights in the diagnosis and management of optico-spinal demyelinating diseases.​

Session date: 
02/16/2026 - 4:00pm to 5:00pm CST
Location: 
Virtually
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Please login or register to take this course.
Discloser List CME Internal Report